Article Information
- Received January 8, 2021
- Accepted February 25, 2021
- Published online March 30, 2021.
- James Weger-Lucarelli, Invited Editor, Virginia Tech
- Nisha Duggal, Editor, Virginia Polytechnic Institute and State University
Author Information
- Address correspondence to Thomas Haselhorst, t.haselhorst{at}griffith.edu.au, or Michael P. Jennings, m.jennings{at}griffith.edu.au.
Christopher J. Day and Benjamin Bailly contributed equally. Co-first order was determined by chronological contribution to the study.
Citation Day CJ, Bailly B, Guillon P, Dirr L, Jen FE-C, Spillings BL, Mak J, von Itzstein M, Haselhorst T, Jennings MP. 2021. Multidisciplinary approaches identify compounds that bind to human ACE2 or SARS-CoV-2 spike protein as candidates to block SARS-CoV-2–ACE2 receptor interactions. mBio 12:e03681-20. https://doi.org/10.1128/mBio.03681-20.
This article is a direct contribution from Michael P. Jennings, a Fellow of the American Academy of Microbiology, who arranged for and secured reviews by Armin Braun, Fraunhofer Institute for Toxicology and Experimental Medicine, and Hui-Ling Yen, University of Hong Kong.